NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission 
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
US, China to Hold AI Talks Ahead of Xi’s September Visit 
Coca-Cola Raises Diet Coke Prices in India as Iran Conflict Disrupts Can Supply 
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations 
Shein Reports $99 Million Loss Ahead of Hong Kong IPO as U.S. Tariffs Hit Sales 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth 
SAP Beats Q2 Revenue Estimates as Cloud Backlog and Business AI Demand Drive Growth. 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline 
Morgan Stanley Downgrades Adobe, Workday as AI Transition Raises Growth Concerns 
Uber Stock Falls as Waymo Plans to End Robotaxi Partnership by 2028 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Elon Musk’s brain-computer interface company Neuralink is preparing for a major expansion, announcing plans to begin high-volume production of its brain implant devices and transition to a fully automated surgical procedure by 2026. The announcement was made by Musk in a post on the social media platform X, highlighting the company’s long-term vision to scale its neurotechnology and make implantation faster, safer, and more accessible.
Neuralink’s brain implant technology is designed to help people with severe neurological conditions, including spinal cord injuries and paralysis, by enabling direct communication between the brain and external devices. The implant allows users to control digital tools using their thoughts, opening new possibilities for restoring independence and improving quality of life. According to previously shared updates, the first patient implanted with the device has successfully used it to play video games, browse the internet, post on social media, and control a laptop cursor without physical movement.
The company began human trials of its brain-computer interface in 2024 after resolving safety concerns raised by the U.S. Food and Drug Administration. The FDA had initially rejected Neuralink’s application in 2022, citing potential risks, but later approved the trials after additional safeguards were implemented. This marked a significant milestone for the company and the broader neurotechnology industry.
In September, Neuralink revealed that 12 people worldwide with severe paralysis had already received its brain implants. These individuals were reportedly using the technology to control both digital and physical tools purely through thought, demonstrating the real-world potential of brain-computer interfaces. The company has also attracted strong investor interest, securing $650 million in a funding round completed in June, further supporting its research, development, and manufacturing goals.
While Neuralink did not immediately respond to a request for comment, Musk’s statement suggests the company is moving toward large-scale deployment. If successful, high-volume production and fully automated surgical implantation could significantly accelerate adoption of brain implant technology, positioning Neuralink as a leader in the rapidly evolving field of neural interfaces and medical innovation.
